|
JAMA Network Open |
Patterns of Alcohol Consumption Among Individuals With Alcohol Use Disorder During the COVID-19 Pandemic and Lockdowns in Germany |
1 |
Yes |
8/8/2025 |
|
American Medical Association |
Prioritizing Equity: Mental Health & COVID-19 |
0.5 |
Yes |
8/8/2025 |
|
American Medical Association |
Prioritizing Equity: Research and Data for Health Equity |
0.75 |
Yes |
8/8/2025 |
|
American Medical Association |
Prioritizing Equity: Structural Racism and the Latinx Community |
0.75 |
Yes |
8/8/2025 |
|
American Medical Association |
Prioritizing Equity: The Root Cause |
1 |
Yes |
8/8/2025 |
|
American Medical Association |
Prioritizing Equity: The Root Cause and Considerations for Health Care Professionals |
1 |
Yes |
8/8/2025 |
|
American Medical Association |
Prioritizing Equity: Trustworthiness & Vaccines |
0.75 |
Yes |
8/8/2025 |
|
American Medical Association |
Prioritizing Equity: Voting During the COVID-19 Pandemic |
0.5 |
Yes |
8/8/2025 |
|
American Medical Association |
Racism in Medicine: Historical Foundations and Strategies for Advancing Health Equity |
1 |
Yes |
8/8/2025 |
|
JAMA Network Open |
Rate of SARS-CoV-2 Reinfection During an Omicron Wave in Iceland |
1 |
Yes |
8/8/2025 |
|
JAMA |
Serum Cystatin C for Estimation of GFR |
1 |
Yes |
8/8/2025 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Two-Year Prevalence and Recovery Rate of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19 |
1 |
Yes |
8/8/2025 |
|
University of California, Irvine School of Medicine |
Risk Management Essentials |
22 |
Yes |
8/9/2025 |
|
JAMA Dermatology |
Multiple Skin-Colored Subcutaneous Nodules in a Girl |
1 |
Yes |
8/10/2025 |
|
JAMA Ophthalmology |
A Recurrent Orbital Hemorrhage in an Older Adult |
1 |
Yes |
8/11/2025 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Parotid Mass in an 81-Year-Old Woman |
1 |
Yes |
8/11/2025 |
|
American Society of Addiction Medicine |
ASAM Motivational Interviewing Workshop |
8 |
Yes |
8/15/2025 |
|
JAMA Oncology |
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19 |
1 |
Yes |
8/16/2025 |
|
JAMA Oncology |
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19 |
1 |
Yes |
8/16/2025 |
|
JAMA Network Open |
Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months |
1 |
Yes |
8/16/2025 |
